Skip to main content
FeaturedDaily
Back to all news

Anthropic

Ben Bernanke Joins Anthropic's Long-Term Benefit Trust

The former Fed chair and Nobel laureate becomes the fourth trustee of Anthropic's independent oversight body, arriving just as the company reportedly heads towards an IPO.

By , Editor-in-Chief · FeaturedDailyVerified July 2026

The answer

Anthropic named Ben Bernanke its fourth Long-Term Benefit Trust trustee on 9 July.

What happened

Dr. Ben Bernanke — Fed chair from 2006 to 2014, 2022 Nobel laureate in economics, now a Distinguished Fellow at Brookings — has joined Anthropic's Long-Term Benefit Trust (LTBT). He becomes the fourth trustee, and a fifth is planned. His mandate leans into the question Anthropic studies most: how AI is reshaping the economy and the labour market — the area where a former central banker's read on jobs, wages and growth carries the most weight. In his appointment statement, Bernanke said how AI's potential plays out "will depend, in part, on the institutions we build around it."

Bernanke joins three existing trustees, each brought in for a distinct lens on Anthropic's mission:

  • Neil Buddy Shah — global health, of the Clinton Health Access Initiative.
  • Richard Fontaine — national security.
  • Mariano-Florentino Cuéllar — international affairs.

He will lend his insight to our economic research, in addition to other areas of Anthropic's work.

Source: Anthropic · 9 July 2026

What the trust does

The LTBT is a September-2023 Delaware purpose trust. It holds a special stock class — Class T shares — that lets trustees elect a growing share of Anthropic's board over time, aiming for majority control within four years of formation. Trustees are independent: no equity, no profit share, paid only for their time. In plain terms, the trust can eventually outvote shareholders if it judges the company is drifting from its safety mission.

Why it matters

The timing is the story. The appointment lands as Anthropic reportedly filed confidentially for an IPO — a target as soon as ~October 2026 at a roughly $965B valuation, per Bloomberg. So a former central banker is joining the oversight body just as the company heads to public markets, where independent trustees and investors will share the room.

Bloomberg reported that Anthropic has confidentially filed for an IPO, with a target as soon as around October 2026 at a valuation near $965 billion (Bloomberg).

Watch the mechanism, not the name. The LTBT's leverage rests on the Class T shares and the four-year path to a board majority — a marquee economist adds credibility, but the teeth are structural. As Anthropic moves towards public markets, whether that independent oversight holds up against shareholder pressure is the real test, and the fifth trustee seat is still open.

Frequently asked questions

Who is Ben Bernanke and what is his role at Anthropic?
Ben Bernanke chaired the U.S. Federal Reserve from 2006 to 2014 and won the 2022 Nobel Prize in economics. He is now the fourth trustee of Anthropic's Long-Term Benefit Trust, focused on AI's impact on the economy and labour market.
What is Anthropic's Long-Term Benefit Trust?
It is an independent Delaware purpose trust created in September 2023 that holds Class T shares. Those shares let trustees elect a growing share of Anthropic's board, aiming for majority control within four years to keep the company aligned with its safety mission.
Is Anthropic going public?
Anthropic has reportedly filed confidentially for an IPO, with a target as soon as around October 2026 at a valuation near $965 billion, according to Bloomberg. The filing is confidential, so timing and terms are not final.
Do the trustees get paid or hold equity?
No. LTBT trustees hold no equity and take no profit share; they are compensated only for their time. New trustees are chosen by existing ones in consultation with the company.

Sources

← All news